(Q43584647)

English

Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

scientific article published on 19 December 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

dermatomyositis

0 references

1 reference

based on heuristic

inferred from title

interstitial lung disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Kazumitsu Sugiura

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Masashi Akiyama

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

395-398

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-2142-X

21 January 2018

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23250474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-012-2142-X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43584647&oldid=2101678794"